Purpose: Aberrant DNA methylation changes are common somatic alterations in prostate carcinogenesis. We examined the methylation status of six genes in prostate tissue specimens from African American (AA) and Caucasian (Cau) males. Experimental Design: We used pyrosequencing to quantitatively measure the methylation status of GSTP1, AR, RARβ2, SPARC, TIMP3, and NKX2-5. Real-time PCR was used to determine gene expression, and gene reactivation was analyzed by 5-aza-2′-deoxycytidine and/or trichostatin A treatment. Results: Statistical analysis showed significantly higher methylation in the prostate cancer tissue samples in comparison with matched normal samples for GSTP1 (P = 0.0001 for AA; P = 0.0008 for Cau), RARβ2 (P \u3c 0.001 for AA and...
African American (AA) men have a higher incidence and significantly higher mortality rates from pros...
Aberrant DNA methylation in gene promoters causes gene silencing and is a common event in prostate c...
Prostate cancer (PCa) is the most common malignancy in men. Epigenetic alterations, including DNA me...
Purpose: Aberrant DNA methylation changes are common somatic alterations in prostate carcinogenesis....
<div><p>Increasing evidence suggests that aberrant DNA methylation changes may contribute to prostat...
The objective of this work was to investigate the clinical significance of promoter gene DNA methyla...
PURPOSE: The diagnosis of localized prostate cancer is difficult due to a lack of cancer-specific bi...
<div><p>Many differentially methylated genes have been identified in prostate cancer (PCa), primaril...
Purpose: Detection of DNA hypermethylation has emerged as a novel molecular biomarker for prostate ...
DNA methylation alterations as a result of field cancerization may be used as diagnostic biomarkers ...
Introduction<p>The current methodology involving diagnosis of prostate cancer (PCa) relies on the pa...
Purpose: Detection of DNA hypermethylation is emerging as a novel molecular biomarker for different ...
Altered genome methylation is a hallmark of human malignancies. In this study, high-throughput analy...
Aberrant DNA methylation is one of the hallmarks of carcinogenesis and has been recognized in cancer...
SummaryA critical need in understanding the biology of prostate cancer is characterizing the molecul...
African American (AA) men have a higher incidence and significantly higher mortality rates from pros...
Aberrant DNA methylation in gene promoters causes gene silencing and is a common event in prostate c...
Prostate cancer (PCa) is the most common malignancy in men. Epigenetic alterations, including DNA me...
Purpose: Aberrant DNA methylation changes are common somatic alterations in prostate carcinogenesis....
<div><p>Increasing evidence suggests that aberrant DNA methylation changes may contribute to prostat...
The objective of this work was to investigate the clinical significance of promoter gene DNA methyla...
PURPOSE: The diagnosis of localized prostate cancer is difficult due to a lack of cancer-specific bi...
<div><p>Many differentially methylated genes have been identified in prostate cancer (PCa), primaril...
Purpose: Detection of DNA hypermethylation has emerged as a novel molecular biomarker for prostate ...
DNA methylation alterations as a result of field cancerization may be used as diagnostic biomarkers ...
Introduction<p>The current methodology involving diagnosis of prostate cancer (PCa) relies on the pa...
Purpose: Detection of DNA hypermethylation is emerging as a novel molecular biomarker for different ...
Altered genome methylation is a hallmark of human malignancies. In this study, high-throughput analy...
Aberrant DNA methylation is one of the hallmarks of carcinogenesis and has been recognized in cancer...
SummaryA critical need in understanding the biology of prostate cancer is characterizing the molecul...
African American (AA) men have a higher incidence and significantly higher mortality rates from pros...
Aberrant DNA methylation in gene promoters causes gene silencing and is a common event in prostate c...
Prostate cancer (PCa) is the most common malignancy in men. Epigenetic alterations, including DNA me...